AAAAAA
Results: 26-47/47
Authors:
HECKLOSTREICHER B
WOSNIK A
KIRSCHFINK M
Citation: B. Hecklostreicher et al., PROTECTION OF PORCINE ENDOTHELIAL-CELLS FROM COMPLEMENT-MEDIATED CYTOTOXICITY BY THE HUMAN-COMPLEMENT REGULATORS CD59, C1 INHIBITOR, AND SOLUBLE COMPLEMENT RECEPTOR-TYPE-1 - ANALYSIS IN A PIG-TO-HUMAN IN-VITROMODEL RELEVANT TO HYPERACUTE XENOGRAFT REJECTION, Transplantation, 62(11), 1996, pp. 1693-1696
Authors:
KRANZLIN B
REUSS A
GRETZ N
KIRSCHFINK M
RYAN CJ
MUJAIS SK
Citation: B. Kranzlin et al., RECOVERY FROM ISCHEMIC ACUTE-RENAL-FAILURE - INDEPENDENCE FROM DIALYSIS MEMBRANE TYPE, Nephron, 73(4), 1996, pp. 644-651
Authors:
SUSAL C
KIRSCHFINK M
KROPELIN M
DANIEL V
OPELZ G
Citation: C. Susal et al., IDENTIFICATION OF COMPLEMENT ACTIVATION SITES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP120, Blood, 87(6), 1996, pp. 2329-2336
Authors:
KIRSCHFINK M
Citation: M. Kirschfink, PHARMACOLOGICAL INFLUENCE ON THE COMPLEME NT-SYSTEM - POSSIBILITIES AND LIMITATIONS OF AN ANTIINFLAMMATORY TREATMENT, Deutsche Medizinische Wochenschrift, 120(31-32), 1995, pp. 1087-1090
Authors:
HECKLOSTREICHER B
KIRSCHFINK M
Citation: B. Hecklostreicher et M. Kirschfink, INFLUENCING THE COMPLEMENT-SYSTEM PHARMAC OLOGICALLY - A CHANCE FOR ASUCCESSFUL XENOTRANSPLANTATION, Immunitat und Infektion, 23(2), 1995, pp. 53-54
Authors:
KIRSCHFINK M
WIENERT T
PRADO EBD
POMER S
Citation: M. Kirschfink et al., ON THE IMPLICATION OF THE COMPLEMENT-SYST EM IN ACUTE REVERSIBLE RENAL CRAFT REJECTION, Immunitat und Infektion, 23(2), 1995, pp. 55-56
Authors:
GRUMACH AS
KIRSCHFINK M
Citation: As. Grumach et M. Kirschfink, COMPLEMENT AND IGG SUBCLASSES IN AGAMMAGLOBULINEMIC PATIENTS, Experimental and clinical immunogenetics, 12(1), 1995, pp. 10-15
Authors:
HIDVEGI T
SCHMIDT B
VARGA L
DERVADERICS M
LANTOS A
GONCZI Z
BAROK J
OTOS M
KIRSCHFINK M
SPATH P
FUST G
Citation: T. Hidvegi et al., IN-VITRO COMPLEMENT ACTIVATION BY RAGWEED ALLERGEN EXTRACT IN THE SERA OF RAGWEED ALLERGIC AND NONALLERGIC PERSONS, Immunology letters, 48(1), 1995, pp. 65-71
Authors:
GRUMACH AS
BELLINATTIPIRES R
PASTORINO AC
JACOB CMA
DIOGO CL
BRANDAO AC
KIRSCHFINK M
DUARTE AJS
Citation: As. Grumach et al., PRIMARY IMMUNODEFICIENCIES IN BRAZILIAN CHILDREN, Journal of allergy and clinical immunology, 95(1), 1995, pp. 237-237
Authors:
PETRY F
LE DT
KIRSCHFINK M
LOOS M
Citation: F. Petry et al., NONSENSE AND MISSENSE MUTATIONS IN THE STRUCTURAL GENES OF COMPLEMENTCOMPONENT C1Q A-CHAINS AND C-CHAINS ARE LINKED WITH 2 DIFFERENT TYPESOF COMPLETE SELECTIVE C1Q DEFICIENCIES, The Journal of immunology, 155(10), 1995, pp. 4734-4738
Authors:
HECKLOSTREICHER B
BINDER R
KIRSCHFINK M
Citation: B. Hecklostreicher et al., FUNCTIONAL-ACTIVITY OF THE MEMBRANE-ASSSOCIATED COMPLEMENT INHIBITOR CD59 IN A PIG-TO-HUMAN IN-VITRO MODEL FOR HYPERACUTE XENOGRAFT REJECTION, Clinical and experimental immunology, 102(3), 1995, pp. 589-595
Authors:
TERNESS P
KIRSCHFINK M
NAVOLAN D
DUFTER C
KOHL I
OPELZ G
ROELCKE D
Citation: P. Terness et al., STRIKING INVERSE CORRELATION BETWEEN IGG ANTI-F(AB')(2) AND AUTOANTIBODY PRODUCTION IN PATIENTS WITH COLD AGGLUTINATION, Blood, 85(2), 1995, pp. 548-551
Authors:
KIRSCHFINK M
Citation: M. Kirschfink, DISORDERS OF THE COMPLEMENT-SYSTEM - CLIN ICAL AND DIAGNOSTIC ASPECTS, Deutsche Medizinische Wochenschrift, 119(9), 1994, pp. 307-310
Authors:
KRANZLIN B
REUSS A
GRETZ N
KIRSCHFINK M
RYAN CJ
MUJAIS S
Citation: B. Kranzlin et al., RECOVERY FROM ISCHEMIC ACUTE-RENAL-FAILURE - INDEPENDENCE FROM DIALYSIS MEMBRANE TYPE, Journal of the American Society of Nephrology, 5(3), 1994, pp. 460-460
Authors:
CAVALCANTI FCB
YOKOO M
PAULA FJ
PRADO MJBA
MALHEIROS DMAC
SABBAGA E
ARAP S
MARCONDES M
KIRSCHFINK M
Citation: Fcb. Cavalcanti et al., ISCHEMIA-REPERFUSION CAUSES COMPLEMENT ACTIVATION (CA) AND BETA-2-INTEGRIN EXPRESSION IN CADAVERIC KIDNEY-TRANSPLANTATION, Journal of the American Society of Nephrology, 5(3), 1994, pp. 997-997
Authors:
KIRSCHFINK M
KNOBLAUCH K
ROELCKE D
Citation: M. Kirschfink et al., ACTIVATION OF COMPLEMENT BY COLD AGGLUTININS, Infusionstherapie und Transfusionsmedizin, 21(6), 1994, pp. 405-409
Authors:
ZILOW G
KIRSCHFINK M
ROELCKE D
Citation: G. Zilow et al., RED-CELL DESTRUCTION IN COLD AGGLUTININ DISEASE, Infusionstherapie und Transfusionsmedizin, 21(6), 1994, pp. 410-415
Authors:
SUSAL C
KIRSCHFINK M
KROPELIN M
DANIEL V
OPELZ G
Citation: C. Susal et al., COMPLEMENT ACTIVATION BY RECOMBINANT HIV-1 GLYCOPROTEIN GP120, The Journal of immunology, 152(12), 1994, pp. 6028-6034
Authors:
KINSCHERF R
KIRSCHFINK M
STROBEL G
WEICKER H
Citation: R. Kinscherf et al., INFLUENCE ON MYOADENYLATE DEAMINASE FUNCTION IN RAT SKELETAL-MUSCLE AFTER HOMOLOGOUS AND HETEROLOGOUS IMMUNIZATION WITH THE PURIFIED ENZYME, International journal of sports medicine, 14(4), 1993, pp. 214-219
Authors:
KIRSCHFINK M
KOVACS B
MOTTAGHY K
Citation: M. Kirschfink et al., EXTRACORPOREAL-CIRCULATION - IN-VIVO AND IN-VITRO ANALYSIS OF COMPLEMENT ACTIVATION BY HEPARIN-BONDED SURFACES, Circulatory shock, 40(3), 1993, pp. 221-226
Authors:
KIRSCHFINK M
KAN G
BINDER R
CLEVE H
GIERSCHICK P
ROTHER K
Citation: M. Kirschfink et al., GC-GLOBULIN (VITAMIN-D-BINDING PROTEIN) MODULATES C5A-MEDIATED BIOLOGICAL-ACTIVITY, The Journal of immunology, 150(8), 1993, pp. 213-213
Authors:
KIRSCHFINK M
PETRY F
KHIRWADKAR K
WIGAND R
KALTWASSER JP
LOOS M
Citation: M. Kirschfink et al., COMPLETE FUNCTIONAL C1Q DEFICIENCY ASSOCIATED WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Clinical and experimental immunology, 94(2), 1993, pp. 267-272